Xencor, Inc Net Income (Loss) Attributable to Noncontrolling Interest
Xencor, Inc (XNCR) reported Net Income (Loss) Attributable to Noncontrolling Interest of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2026-08-05
- Xencor, Inc net income (loss) attributable to noncontrolling interest for the quarter ending 2026-06-30 was $0.00.
- Xencor, Inc net income (loss) attributable to noncontrolling interest for the quarter ending 2026-03-31 was $0.00.
- Xencor, Inc net income (loss) attributable to noncontrolling interest for the quarter ending 2025-12-31 was $0.00.
- Xencor, Inc net income (loss) attributable to noncontrolling interest for the quarter ending 2025-09-30 was $0.00.
- Xencor, Inc net income (loss) attributable to noncontrolling interest for fiscal 2025 was -$214.00K.
- Xencor, Inc net income (loss) attributable to noncontrolling interest for fiscal 2024 was -$3.92M.
- Xencor, Inc net income (loss) attributable to noncontrolling interest for fiscal 2023 was -$163.00K.
- Xencor, Inc net income (loss) attributable to noncontrolling interest for fiscal 2022 was $0.00.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-05 | $0.00 10-Q · filed 2026-08-05 | $0.00 derived: sum of 3 quarters · filed 2026-08-05 | $0.00 derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-06 | $0.00 derived: sum of 2 quarters · filed 2026-05-06 | $0.00 derived: sum of 3 quarters · filed 2026-05-06 | $0.00 derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $0.00 derived: sum of 2 quarters · filed 2026-02-25 | $0.00 derived: sum of 3 quarters · filed 2026-08-05 | -$214.00K 10-K · filed 2026-02-25 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2026-08-05 | -$214.00K 10-Q · filed 2025-11-05 | -$861.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-05 | -$214.00K 10-Q · filed 2026-08-05 | -$861.00K derived: sum of 3 quarters · filed 2026-08-05 | -$2.02M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$214.00K 10-Q · filed 2026-05-06 | -$861.00K derived: sum of 2 quarters · filed 2026-05-06 | -$2.02M derived: sum of 3 quarters · filed 2026-05-06 | -$3.46M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$647.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$1.80M derived: sum of 2 quarters · filed 2026-02-25 | -$3.25M derived: sum of 3 quarters · filed 2026-02-25 | -$3.92M 10-K · filed 2026-02-25 |
| 2024-09-30 | -$1.15M 10-Q · filed 2025-11-05 | -$2.60M derived: sum of 2 quarters · filed 2025-11-05 | -$3.27M 10-Q · filed 2025-11-05 | -$3.44M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | -$1.45M 10-Q · filed 2025-08-06 | -$2.12M 10-Q · filed 2025-08-06 | -$2.28M derived: sum of 3 quarters · filed 2026-02-25 | -$2.28M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | -$676.00K 10-Q · filed 2025-05-07 | -$839.00K derived: sum of 2 quarters · filed 2026-02-25 | -$839.00K derived: sum of 3 quarters · filed 2026-02-25 | -$839.00K derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | -$163.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-02-25 | -$163.00K derived: sum of 2 quarters · filed 2026-02-25 | -$163.00K derived: sum of 3 quarters · filed 2026-02-25 | -$163.00K 10-K · filed 2026-02-25 |
| 2023-09-30 | $0.00 10-Q/A · filed 2025-02-24 | $0.00 derived: sum of 2 quarters · filed 2025-02-24 | $0.00 10-Q/A · filed 2025-02-24 | |
| 2023-06-30 | $0.00 10-Q/A · filed 2025-02-24 | $0.00 10-Q/A · filed 2025-02-24 | ||
| 2023-03-31 | $0.00 10-Q/A · filed 2025-02-24 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-02-27 | |||
| 2021-12-31 | $0.00 10-K/A · filed 2025-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |